REQUEST A DEMO
Total
USD $0.00
Search more companies

Jandus Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: JANDUS PHARMA Egeszsegugyi Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Jandus Pharma Kft. is based in Hungary, with the head office in Gyongyos. The company operates in the Pharmacies and Drug Stores sector. It was first established on April 16, 2007. It currently has a total number of 4 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 14.55% in 2023. A growth of 21.47% was recorded in its total assets. In 2023, Jandus Pharma Kft.’s net profit margin increased by 0.47%.

Headquarters
Deak Ferenc utca 44.
Gyongyos; Heves; Postal Code: 3200

Contact Details: Purchase the Jandus Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Jandus Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Jandus Pharma Kft. report to view the information.
Registered Capital:
Purchase the Jandus Pharma Kft. report to view the information.
Incorporation Date:
April 16, 2007
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Jandus Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.55%
Total operating revenue
14.17%
Operating profit (EBIT)
21.27%
EBITDA
17.45%
Net Profit (Loss) for the Period
36.36%
Total assets
21.47%
Total equity
-17.98%
Operating Profit Margin (ROS)
0.17%
Net Profit Margin
0.47%
Return on Equity (ROE)
33.95%
Quick Ratio
-0.16%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?